OBJECTIVE: In this study, we investigated matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) in cerebrospinal fluid (CSF) and plasma of traumatic brain injury (TBI) patients. PATIENTS AND METHODS: A total of 30 patients with moderate and severe TBI and 15 age-matched controls were enrolled in this study. Plasma and CSF samples were collected within 24 h (as the initial value), at 72 and 120 h post injury. CSF and plasma MMP-9, MMP-2, TIMP-1 and TIMP-2 were estimated using ELISA. Different levels of these indexes were compared in the two groups and further investigated the correlation between each other. RESULTS: There was a significant elevation in the levels of the initial MMP-9 in the CSF (P < 0.05), which lasted for 72 h post injury. TIMP-1 kept increasing within 120 h post injury and it was different compared with TIMP-1 at 24 and 72 h post injury. Plasma levels of MMP-9, MMP-2, TIMP-1 and TIMP-2 in TBI patients were also significantly different from those in controls. Furthermore the CSF MMP-9 in patients with severe TBI was higher than that in patients with moderate TBI. In addition, there was a positive relationship between the initial MMP-9 and TIMP-1 at 120 h post injury (r = 0.614, P < 0.01). CONCLUSION: MMPs and TIMPs are increased in both CSF and plasma of TBI patients. TIMP-1 has a positive correlation with MMP-9 and the initial MMP-9 is associated with the neurological outcomes.
OBJECTIVE: In this study, we investigated matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) in cerebrospinal fluid (CSF) and plasma of traumatic brain injury (TBI) patients. PATIENTS AND METHODS: A total of 30 patients with moderate and severe TBI and 15 age-matched controls were enrolled in this study. Plasma and CSF samples were collected within 24 h (as the initial value), at 72 and 120 h post injury. CSF and plasma MMP-9, MMP-2, TIMP-1 and TIMP-2 were estimated using ELISA. Different levels of these indexes were compared in the two groups and further investigated the correlation between each other. RESULTS: There was a significant elevation in the levels of the initial MMP-9 in the CSF (P < 0.05), which lasted for 72 h post injury. TIMP-1 kept increasing within 120 h post injury and it was different compared with TIMP-1 at 24 and 72 h post injury. Plasma levels of MMP-9, MMP-2, TIMP-1 and TIMP-2 in TBI patients were also significantly different from those in controls. Furthermore the CSF MMP-9 in patients with severe TBI was higher than that in patients with moderate TBI. In addition, there was a positive relationship between the initial MMP-9 and TIMP-1 at 120 h post injury (r = 0.614, P < 0.01). CONCLUSION:MMPs and TIMPs are increased in both CSF and plasma of TBI patients. TIMP-1 has a positive correlation with MMP-9 and the initial MMP-9 is associated with the neurological outcomes.
Authors: Mathew R Guilfoyle; Keri L H Carpenter; Adel Helmy; John D Pickard; David K Menon; Peter J A Hutchinson Journal: J Neurotrauma Date: 2015-05-14 Impact factor: 5.269
Authors: Sindhu K Madathil; Bernard S Wilfred; Sarah E Urankar; Weihong Yang; Lai Yee Leung; Janice S Gilsdorf; Deborah A Shear Journal: Front Neurol Date: 2018-11-15 Impact factor: 4.003
Authors: Mareen Braunstein; Thomas Kusmenkov; Wolf Mutschler; Christian Kammerlander; Wolfgang Böcker; Viktoria Bogner-Flatz Journal: J Immunol Res Date: 2020-03-09 Impact factor: 4.818
Authors: Bridgette D Semple; Linda J Noble-Haeusslein; Major Gooyit; Kayleen G Tercovich; Zhihong Peng; Trung T Nguyen; Valerie A Schroeder; Mark A Suckow; Mayland Chang; Jacob Raber; Alpa Trivedi Journal: PLoS One Date: 2015-11-20 Impact factor: 3.240
Authors: Karolina Minta; Gunnar Brinkmalm; Faiez Al Nimer; Eric P Thelin; Fredrik Piehl; Mats Tullberg; Anna Jeppsson; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Ulf Andreasson Journal: Sci Rep Date: 2020-10-22 Impact factor: 4.379